Two Sigma Investments’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,423
Closed -$364K 3632
2017
Q3
$364K Sell
12,423
-5,435
-30% -$152K ﹤0.01% 2327
2017
Q2
$469K Buy
+17,858
New +$439K ﹤0.01% 2387
2016
Q1
Sell
-69,202
Closed -$2.42M 3301
2015
Q4
$2.42M Buy
+69,202
New +$2.17M 0.01% 996
2015
Q3
Sell
-153,975
Closed -$5.13M 3047
2015
Q2
$5.13M Buy
153,975
+42,231
+38% +$1.3M 0.02% 715
2015
Q1
$3.15M Buy
111,744
+99,331
+800% +$2.47M 0.01% 935
2014
Q4
$257K Buy
+12,413
New +$295K ﹤0.01% 1964
2014
Q3
Sell
-61,406
Closed -$1.76M 2249
2014
Q2
$1.76M Buy
61,406
+27,552
+81% +$766K 0.01% 1087
2014
Q1
$947K Sell
33,854
-84,449
-71% -$2.07M 0.01% 1233
2013
Q4
$2.54M Buy
+118,303
New +$2.15M 0.01% 903

Two Sigma Investments's PMC Position: Q4 2017 in Review

Two Sigma Investments sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 12,423 shares — an estimated $364K sold.

Two Sigma Investments first reported a position in PMC in Q4 2013 and held it in 9 quarters. The position peaked at $5.13M in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Two Sigma Investments reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Two Sigma Investments sold 12,423 PharMerica Corporation shares in Q4 2017, an estimated $364K.
  • Two Sigma Investments first reported a position in PharMerica Corporation in Q4 2013 and held it in 9 quarters.
  • Two Sigma Investments's PharMerica Corporation position peaked at $5.13M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Two Sigma Investments's 13F filing for Q4 2017, filed 14 Feb 2018.